MR编号 | NL/H/0299/001 |
---|
药品名称 | Spiriva 18 microgram |
---|
活性成分 | - tiotropium bromide monohydrate 22.5 µg
|
---|
剂型 | Inhalation powder, hard capsule |
---|
上市许可持有人 | Boehringer Ingelheim International GmbH
Bingerstrasse 173
D-55216 Ingelheim am Rhein
Germany |
---|
参考成员国 - 产品名称 | Netherlands (NL) Spiriva 18 microgram, inhalatiepoeder in harde capsules |
---|
互认成员国 - 产品名称 | - Liechtenstein (LI)
- Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Spiriva 18µg - France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Latvia (LV)
- Lithuania (LT)
Spiriva 18 mikrogramų įkvepiamieji milteliai (kietosios kapsulės) - Hungary (HU)
SPIRIVA 18 mikrogramm inhalációs por kemény kapszulában - Bulgaria (BG)
Spiriva - Cyprus (CY)
SPIRIVA INHALATION PWD HARD CAPS - Czechia (CZ)
Spiriva - Romania (RO)
Spiriva 18 micrograme capsule cu pulbere de inhalat - Slovakia (SK)
Spiriva - Slovenia (SI)
- Malta (MT)
Spiriva 18 microgram, inhalation powder, hard capsule
|
---|
许可日期 | 2002/04/02 |
---|
最近更新日期 | 2024/10/25 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|